WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr | ₹3.59 Cr | ₹2.88 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹3.95 Cr |
Mar2023 | ₹3.44 Cr |
Mar2022 | ₹0.21 Cr |
Mar2021 | ₹3.59 Cr |
Mar2020 | ₹2.88 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3.95 Cr | 14.84 | |
Mar2023 | ₹3.44 Cr | 1,513.62 | |
Mar2022 | ₹0.21 Cr | -94.06 | |
Mar2021 | ₹3.59 Cr | 24.61 | |
Mar2020 | ₹2.88 Cr | - |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹1,755.4 Cr | -16.6% | -16.7% | 73.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,044.0 Cr | -0.2% | -1% | 9.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,537.0 Cr | -2.1% | 1.5% | 61.3% | Stock Analytics | |
CIPLA | ₹118,889.0 Cr | -0% | 2% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,075.0 Cr | -1.4% | -6.1% | -4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,832.5 Cr | -5.2% | -4.7% | 8.9% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -16.6% |
-16.7% |
73.7% |
SENSEX | -2.5% |
-0.8% |
7.1% |
You may also like the below Video Courses